nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticlopidine—CYP1A1—Dacarbazine—melanoma	0.15	0.201	CbGbCtD
Ticlopidine—CYP2E1—Dacarbazine—melanoma	0.116	0.155	CbGbCtD
Ticlopidine—CYP1A2—Carmustine—melanoma	0.111	0.148	CbGbCtD
Ticlopidine—CYP1A2—Vemurafenib—melanoma	0.0877	0.117	CbGbCtD
Ticlopidine—CYP3A4—Temozolomide—melanoma	0.0838	0.112	CbGbCtD
Ticlopidine—CYP2D6—Vemurafenib—melanoma	0.0722	0.0963	CbGbCtD
Ticlopidine—CYP1A2—Dacarbazine—melanoma	0.0672	0.0896	CbGbCtD
Ticlopidine—CYP3A4—Vemurafenib—melanoma	0.0459	0.0612	CbGbCtD
Ticlopidine—CYP3A4—Docetaxel—melanoma	0.0158	0.021	CbGbCtD
Ticlopidine—Diarrhoea haemorrhagic—Docetaxel—melanoma	0.00399	0.0344	CcSEcCtD
Ticlopidine—Vasculitis—Vemurafenib—melanoma	0.00304	0.0262	CcSEcCtD
Ticlopidine—Lupus erythematosus—Docetaxel—melanoma	0.0027	0.0233	CcSEcCtD
Ticlopidine—Lung disorder—Temozolomide—melanoma	0.00214	0.0185	CcSEcCtD
Ticlopidine—Eosinophilia—Vemurafenib—melanoma	0.00184	0.0159	CcSEcCtD
Ticlopidine—Systemic lupus erythematosus—Docetaxel—melanoma	0.00182	0.0157	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.00164	0.0142	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Vemurafenib—melanoma	0.00163	0.014	CcSEcCtD
Ticlopidine—Sepsis—Dactinomycin—melanoma	0.00145	0.0125	CcSEcCtD
Ticlopidine—Erythema multiforme—Vemurafenib—melanoma	0.00141	0.0121	CcSEcCtD
Ticlopidine—Sepsis—Carmustine—melanoma	0.00136	0.0117	CcSEcCtD
Ticlopidine—Hepatic failure—Dactinomycin—melanoma	0.00135	0.0117	CcSEcCtD
Ticlopidine—Diabetes mellitus—Carmustine—melanoma	0.00131	0.0113	CcSEcCtD
Ticlopidine—Vascular purpura—Temozolomide—melanoma	0.00123	0.0106	CcSEcCtD
Ticlopidine—Hepatic failure—Temozolomide—melanoma	0.00122	0.0106	CcSEcCtD
Ticlopidine—Dermatitis exfoliative—Temozolomide—melanoma	0.00117	0.0101	CcSEcCtD
Ticlopidine—Hyponatraemia—Carmustine—melanoma	0.00114	0.00986	CcSEcCtD
Ticlopidine—Purpura—Temozolomide—melanoma	0.00114	0.00985	CcSEcCtD
Ticlopidine—Gastrointestinal haemorrhage—Carmustine—melanoma	0.00114	0.00982	CcSEcCtD
Ticlopidine—Liver function test abnormal—Dactinomycin—melanoma	0.00112	0.00969	CcSEcCtD
Ticlopidine—Myalgia—Vemurafenib—melanoma	0.0011	0.00952	CcSEcCtD
Ticlopidine—Arthralgia—Vemurafenib—melanoma	0.0011	0.00952	CcSEcCtD
Ticlopidine—Pancytopenia—Bleomycin—melanoma	0.00107	0.00924	CcSEcCtD
Ticlopidine—Anaphylactic shock—Vemurafenib—melanoma	0.00106	0.00913	CcSEcCtD
Ticlopidine—Liver function test abnormal—Carmustine—melanoma	0.00105	0.00907	CcSEcCtD
Ticlopidine—Pancytopenia—Dactinomycin—melanoma	0.000998	0.00861	CcSEcCtD
Ticlopidine—Colitis—Docetaxel—melanoma	0.000967	0.00835	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000964	0.00832	CcSEcCtD
Ticlopidine—Haematuria—Bleomycin—melanoma	0.000958	0.00827	CcSEcCtD
Ticlopidine—Abdominal distension—Temozolomide—melanoma	0.000957	0.00826	CcSEcCtD
Ticlopidine—Pancytopenia—Carmustine—melanoma	0.000934	0.00806	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000929	0.00802	CcSEcCtD
Ticlopidine—Decreased appetite—Vemurafenib—melanoma	0.000919	0.00794	CcSEcCtD
Ticlopidine—Haemoglobin—Bleomycin—melanoma	0.000907	0.00782	CcSEcCtD
Ticlopidine—Pancytopenia—Temozolomide—melanoma	0.000903	0.00779	CcSEcCtD
Ticlopidine—Haemorrhage—Bleomycin—melanoma	0.000902	0.00778	CcSEcCtD
Ticlopidine—Sepsis—Docetaxel—melanoma	0.000874	0.00755	CcSEcCtD
Ticlopidine—Renal failure—Carmustine—melanoma	0.000862	0.00744	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Carmustine—melanoma	0.00086	0.00742	CcSEcCtD
Ticlopidine—Hepatitis—Dactinomycin—melanoma	0.000841	0.00726	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Temozolomide—melanoma	0.00084	0.00725	CcSEcCtD
Ticlopidine—Body temperature increased—Vemurafenib—melanoma	0.000836	0.00722	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Temozolomide—melanoma	0.000831	0.00717	CcSEcCtD
Ticlopidine—Hepatic failure—Docetaxel—melanoma	0.000814	0.00702	CcSEcCtD
Ticlopidine—Erythema multiforme—Dactinomycin—melanoma	0.000795	0.00686	CcSEcCtD
Ticlopidine—Haemoglobin—Carmustine—melanoma	0.000791	0.00683	CcSEcCtD
Ticlopidine—Haemorrhage—Carmustine—melanoma	0.000787	0.0068	CcSEcCtD
Ticlopidine—Clopidogrel—ABCB1—melanoma	0.000785	1	CrCbGaD
Ticlopidine—Hypersensitivity—Vemurafenib—melanoma	0.000779	0.00673	CcSEcCtD
Ticlopidine—Haemoglobin—Temozolomide—melanoma	0.000765	0.0066	CcSEcCtD
Ticlopidine—Haemorrhage—Temozolomide—melanoma	0.000761	0.00657	CcSEcCtD
Ticlopidine—Hepatitis—Temozolomide—melanoma	0.000761	0.00657	CcSEcCtD
Ticlopidine—Asthenia—Vemurafenib—melanoma	0.000759	0.00655	CcSEcCtD
Ticlopidine—Pruritus—Vemurafenib—melanoma	0.000748	0.00646	CcSEcCtD
Ticlopidine—Hyponatraemia—Docetaxel—melanoma	0.000734	0.00634	CcSEcCtD
Ticlopidine—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.000731	0.00631	CcSEcCtD
Ticlopidine—Diarrhoea—Vemurafenib—melanoma	0.000724	0.00625	CcSEcCtD
Ticlopidine—Erythema multiforme—Temozolomide—melanoma	0.000719	0.00621	CcSEcCtD
Ticlopidine—Tinnitus—Temozolomide—melanoma	0.000709	0.00612	CcSEcCtD
Ticlopidine—Dizziness—Vemurafenib—melanoma	0.000699	0.00604	CcSEcCtD
Ticlopidine—Liver function test abnormal—Docetaxel—melanoma	0.000675	0.00583	CcSEcCtD
Ticlopidine—Vomiting—Vemurafenib—melanoma	0.000672	0.0058	CcSEcCtD
Ticlopidine—Myalgia—Bleomycin—melanoma	0.000668	0.00577	CcSEcCtD
Ticlopidine—Rash—Vemurafenib—melanoma	0.000667	0.00576	CcSEcCtD
Ticlopidine—Dermatitis—Vemurafenib—melanoma	0.000666	0.00575	CcSEcCtD
Ticlopidine—Headache—Vemurafenib—melanoma	0.000663	0.00572	CcSEcCtD
Ticlopidine—Cramp muscle—Docetaxel—melanoma	0.000659	0.00568	CcSEcCtD
Ticlopidine—Anaphylactic shock—Bleomycin—melanoma	0.000641	0.00553	CcSEcCtD
Ticlopidine—Nausea—Vemurafenib—melanoma	0.000628	0.00542	CcSEcCtD
Ticlopidine—Thrombocytopenia—Bleomycin—melanoma	0.000627	0.00542	CcSEcCtD
Ticlopidine—Myalgia—Dactinomycin—melanoma	0.000623	0.00538	CcSEcCtD
Ticlopidine—Anorexia—Bleomycin—melanoma	0.000611	0.00527	CcSEcCtD
Ticlopidine—Angioedema—Temozolomide—melanoma	0.000605	0.00522	CcSEcCtD
Ticlopidine—Pancytopenia—Docetaxel—melanoma	0.0006	0.00518	CcSEcCtD
Ticlopidine—Thrombocytopenia—Dactinomycin—melanoma	0.000585	0.00505	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Bleomycin—melanoma	0.000584	0.00504	CcSEcCtD
Ticlopidine—Myalgia—Carmustine—melanoma	0.000583	0.00504	CcSEcCtD
Ticlopidine—Anorexia—Dactinomycin—melanoma	0.00057	0.00492	CcSEcCtD
Ticlopidine—Myalgia—Temozolomide—melanoma	0.000564	0.00487	CcSEcCtD
Ticlopidine—Arthralgia—Temozolomide—melanoma	0.000564	0.00487	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000559	0.00482	CcSEcCtD
Ticlopidine—Decreased appetite—Bleomycin—melanoma	0.000557	0.00481	CcSEcCtD
Ticlopidine—Renal failure—Docetaxel—melanoma	0.000554	0.00478	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Docetaxel—melanoma	0.000552	0.00477	CcSEcCtD
Ticlopidine—Pain—Bleomycin—melanoma	0.000548	0.00473	CcSEcCtD
Ticlopidine—Thrombocytopenia—Carmustine—melanoma	0.000548	0.00473	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000544	0.0047	CcSEcCtD
Ticlopidine—Anaphylactic shock—Temozolomide—melanoma	0.000541	0.00467	CcSEcCtD
Ticlopidine—Anorexia—Carmustine—melanoma	0.000533	0.0046	CcSEcCtD
Ticlopidine—Epistaxis—Docetaxel—melanoma	0.000532	0.00459	CcSEcCtD
Ticlopidine—Thrombocytopenia—Temozolomide—melanoma	0.000529	0.00457	CcSEcCtD
Ticlopidine—Decreased appetite—Dactinomycin—melanoma	0.00052	0.00448	CcSEcCtD
Ticlopidine—Anorexia—Temozolomide—melanoma	0.000515	0.00445	CcSEcCtD
Ticlopidine—Pain—Dactinomycin—melanoma	0.000511	0.00441	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Carmustine—melanoma	0.00051	0.0044	CcSEcCtD
Ticlopidine—Urticaria—Bleomycin—melanoma	0.000509	0.00439	CcSEcCtD
Ticlopidine—Haemoglobin—Docetaxel—melanoma	0.000509	0.00439	CcSEcCtD
Ticlopidine—Body temperature increased—Bleomycin—melanoma	0.000507	0.00437	CcSEcCtD
Ticlopidine—Haemorrhage—Docetaxel—melanoma	0.000506	0.00437	CcSEcCtD
Ticlopidine—Hepatitis—Docetaxel—melanoma	0.000506	0.00437	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Temozolomide—melanoma	0.000492	0.00425	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Dactinomycin—melanoma	0.000489	0.00422	CcSEcCtD
Ticlopidine—Decreased appetite—Carmustine—melanoma	0.000486	0.0042	CcSEcCtD
Ticlopidine—Erythema multiforme—Docetaxel—melanoma	0.000478	0.00413	CcSEcCtD
Ticlopidine—Pain—Carmustine—melanoma	0.000478	0.00413	CcSEcCtD
Ticlopidine—Dyspepsia—Temozolomide—melanoma	0.000476	0.00411	CcSEcCtD
Ticlopidine—Body temperature increased—Dactinomycin—melanoma	0.000472	0.00408	CcSEcCtD
Ticlopidine—Hypersensitivity—Bleomycin—melanoma	0.000472	0.00407	CcSEcCtD
Ticlopidine—Decreased appetite—Temozolomide—melanoma	0.00047	0.00406	CcSEcCtD
Ticlopidine—Pain—Temozolomide—melanoma	0.000462	0.00399	CcSEcCtD
Ticlopidine—Asthenia—Bleomycin—melanoma	0.00046	0.00397	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Carmustine—melanoma	0.000457	0.00395	CcSEcCtD
Ticlopidine—Pruritus—Bleomycin—melanoma	0.000453	0.00391	CcSEcCtD
Ticlopidine—Body temperature increased—Carmustine—melanoma	0.000442	0.00382	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Temozolomide—melanoma	0.000442	0.00382	CcSEcCtD
Ticlopidine—Hypersensitivity—Dactinomycin—melanoma	0.00044	0.0038	CcSEcCtD
Ticlopidine—Urticaria—Temozolomide—melanoma	0.000429	0.00371	CcSEcCtD
Ticlopidine—Asthenia—Dactinomycin—melanoma	0.000429	0.0037	CcSEcCtD
Ticlopidine—Body temperature increased—Temozolomide—melanoma	0.000427	0.00369	CcSEcCtD
Ticlopidine—Muscle spasms—Docetaxel—melanoma	0.000423	0.00365	CcSEcCtD
Ticlopidine—Hypersensitivity—Carmustine—melanoma	0.000412	0.00356	CcSEcCtD
Ticlopidine—Diarrhoea—Dactinomycin—melanoma	0.000409	0.00353	CcSEcCtD
Ticlopidine—Vomiting—Bleomycin—melanoma	0.000407	0.00352	CcSEcCtD
Ticlopidine—Rash—Bleomycin—melanoma	0.000404	0.00349	CcSEcCtD
Ticlopidine—Dermatitis—Bleomycin—melanoma	0.000404	0.00348	CcSEcCtD
Ticlopidine—Asthenia—Carmustine—melanoma	0.000401	0.00346	CcSEcCtD
Ticlopidine—Hypersensitivity—Temozolomide—melanoma	0.000398	0.00344	CcSEcCtD
Ticlopidine—Asthenia—Temozolomide—melanoma	0.000388	0.00335	CcSEcCtD
Ticlopidine—Diarrhoea—Carmustine—melanoma	0.000383	0.0033	CcSEcCtD
Ticlopidine—Pruritus—Temozolomide—melanoma	0.000382	0.0033	CcSEcCtD
Ticlopidine—Nausea—Bleomycin—melanoma	0.000381	0.00329	CcSEcCtD
Ticlopidine—Vomiting—Dactinomycin—melanoma	0.00038	0.00328	CcSEcCtD
Ticlopidine—Rash—Dactinomycin—melanoma	0.000377	0.00325	CcSEcCtD
Ticlopidine—Myalgia—Docetaxel—melanoma	0.000375	0.00324	CcSEcCtD
Ticlopidine—Arthralgia—Docetaxel—melanoma	0.000375	0.00324	CcSEcCtD
Ticlopidine—Dizziness—Carmustine—melanoma	0.00037	0.00319	CcSEcCtD
Ticlopidine—Diarrhoea—Temozolomide—melanoma	0.00037	0.00319	CcSEcCtD
Ticlopidine—Anaphylactic shock—Docetaxel—melanoma	0.000359	0.0031	CcSEcCtD
Ticlopidine—Dizziness—Temozolomide—melanoma	0.000357	0.00309	CcSEcCtD
Ticlopidine—Vomiting—Carmustine—melanoma	0.000356	0.00307	CcSEcCtD
Ticlopidine—Nausea—Dactinomycin—melanoma	0.000355	0.00306	CcSEcCtD
Ticlopidine—Rash—Carmustine—melanoma	0.000353	0.00304	CcSEcCtD
Ticlopidine—Dermatitis—Carmustine—melanoma	0.000352	0.00304	CcSEcCtD
Ticlopidine—Thrombocytopenia—Docetaxel—melanoma	0.000352	0.00304	CcSEcCtD
Ticlopidine—Headache—Carmustine—melanoma	0.00035	0.00302	CcSEcCtD
Ticlopidine—Vomiting—Temozolomide—melanoma	0.000344	0.00297	CcSEcCtD
Ticlopidine—Anorexia—Docetaxel—melanoma	0.000343	0.00296	CcSEcCtD
Ticlopidine—Rash—Temozolomide—melanoma	0.000341	0.00294	CcSEcCtD
Ticlopidine—Dermatitis—Temozolomide—melanoma	0.00034	0.00294	CcSEcCtD
Ticlopidine—Headache—Temozolomide—melanoma	0.000339	0.00292	CcSEcCtD
Ticlopidine—Nausea—Carmustine—melanoma	0.000332	0.00287	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Docetaxel—melanoma	0.000327	0.00283	CcSEcCtD
Ticlopidine—Nausea—Temozolomide—melanoma	0.000321	0.00277	CcSEcCtD
Ticlopidine—Dyspepsia—Docetaxel—melanoma	0.000316	0.00273	CcSEcCtD
Ticlopidine—Decreased appetite—Docetaxel—melanoma	0.000312	0.0027	CcSEcCtD
Ticlopidine—Pain—Docetaxel—melanoma	0.000307	0.00265	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Docetaxel—melanoma	0.000294	0.00254	CcSEcCtD
Ticlopidine—Body temperature increased—Docetaxel—melanoma	0.000284	0.00245	CcSEcCtD
Ticlopidine—Hypersensitivity—Docetaxel—melanoma	0.000265	0.00229	CcSEcCtD
Ticlopidine—Asthenia—Docetaxel—melanoma	0.000258	0.00223	CcSEcCtD
Ticlopidine—Pruritus—Docetaxel—melanoma	0.000254	0.0022	CcSEcCtD
Ticlopidine—Diarrhoea—Docetaxel—melanoma	0.000246	0.00212	CcSEcCtD
Ticlopidine—Dizziness—Docetaxel—melanoma	0.000238	0.00205	CcSEcCtD
Ticlopidine—Vomiting—Docetaxel—melanoma	0.000229	0.00197	CcSEcCtD
Ticlopidine—Rash—Docetaxel—melanoma	0.000227	0.00196	CcSEcCtD
Ticlopidine—Dermatitis—Docetaxel—melanoma	0.000226	0.00195	CcSEcCtD
Ticlopidine—Headache—Docetaxel—melanoma	0.000225	0.00194	CcSEcCtD
Ticlopidine—Nausea—Docetaxel—melanoma	0.000214	0.00184	CcSEcCtD
Ticlopidine—CYP3A4—Metabolism—PLCB4—melanoma	1.9e-05	0.000143	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.88e-05	0.000141	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—GNA11—melanoma	1.87e-05	0.00014	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—MMP9—melanoma	1.87e-05	0.00014	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—SDHD—melanoma	1.87e-05	0.00014	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CSPG4—melanoma	1.87e-05	0.00014	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—BSG—melanoma	1.87e-05	0.00014	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CDKN1A—melanoma	1.86e-05	0.00014	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—PTEN—melanoma	1.86e-05	0.000139	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—NFKB1—melanoma	1.85e-05	0.000139	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—GNA11—melanoma	1.83e-05	0.000137	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—FASN—melanoma	1.83e-05	0.000137	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—CYP17A1—melanoma	1.83e-05	0.000137	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PLA2G6—melanoma	1.82e-05	0.000136	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.82e-05	0.000136	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—AKT1—melanoma	1.81e-05	0.000136	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—GPAM—melanoma	1.81e-05	0.000136	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.81e-05	0.000135	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PLA2G6—melanoma	1.8e-05	0.000135	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—SLC5A5—melanoma	1.8e-05	0.000135	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—FASN—melanoma	1.79e-05	0.000135	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—SLC6A11—melanoma	1.79e-05	0.000134	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PIP4K2A—melanoma	1.79e-05	0.000134	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—ALB—melanoma	1.78e-05	0.000134	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—VCAN—melanoma	1.78e-05	0.000133	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—SLC5A5—melanoma	1.77e-05	0.000132	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—MTAP—melanoma	1.74e-05	0.000131	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—CD44—melanoma	1.74e-05	0.00013	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—GNAQ—melanoma	1.74e-05	0.00013	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—GNA11—melanoma	1.73e-05	0.00013	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—GNAQ—melanoma	1.7e-05	0.000128	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—CD44—melanoma	1.7e-05	0.000128	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—FASN—melanoma	1.69e-05	0.000127	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.68e-05	0.000126	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—VEGFA—melanoma	1.68e-05	0.000126	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—CYP17A1—melanoma	1.68e-05	0.000126	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—CYP1B1—melanoma	1.67e-05	0.000125	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—SLC5A5—melanoma	1.66e-05	0.000125	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—STAT3—melanoma	1.66e-05	0.000125	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—NRAS—melanoma	1.66e-05	0.000124	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.66e-05	0.000124	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—CYP1B1—melanoma	1.63e-05	0.000123	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	1.63e-05	0.000122	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—VCAN—melanoma	1.63e-05	0.000122	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.62e-05	0.000122	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—VCAN—melanoma	1.62e-05	0.000121	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—GNAQ—melanoma	1.61e-05	0.00012	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—CD44—melanoma	1.61e-05	0.00012	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—MAPK3—melanoma	1.59e-05	0.000119	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—GNA11—melanoma	1.58e-05	0.000119	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.57e-05	0.000118	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.56e-05	0.000117	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—LUM—melanoma	1.55e-05	0.000116	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PHGDH—melanoma	1.55e-05	0.000116	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—FASN—melanoma	1.55e-05	0.000116	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—MYC—melanoma	1.55e-05	0.000116	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—CYP1B1—melanoma	1.54e-05	0.000116	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PLA2G6—melanoma	1.54e-05	0.000115	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.53e-05	0.000115	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—SLC5A5—melanoma	1.53e-05	0.000114	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—HPSE—melanoma	1.52e-05	0.000114	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—MAPK1—melanoma	1.51e-05	0.000113	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—EGFR—melanoma	1.51e-05	0.000113	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—CYP17A1—melanoma	1.5e-05	0.000112	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CUBN—melanoma	1.49e-05	0.000112	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.48e-05	0.000111	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.48e-05	0.000111	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—GNAQ—melanoma	1.47e-05	0.00011	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—CD44—melanoma	1.47e-05	0.00011	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	1.46e-05	0.000109	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—SDHD—melanoma	1.44e-05	0.000108	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—BSG—melanoma	1.44e-05	0.000108	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CSPG4—melanoma	1.44e-05	0.000108	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.44e-05	0.000108	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.43e-05	0.000107	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—KRAS—melanoma	1.43e-05	0.000107	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—GNA11—melanoma	1.41e-05	0.000106	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—CYP1B1—melanoma	1.41e-05	0.000106	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GPAM—melanoma	1.4e-05	0.000105	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—FASN—melanoma	1.38e-05	0.000104	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—VCAN—melanoma	1.38e-05	0.000104	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CYP17A1—melanoma	1.38e-05	0.000103	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—ABCB1—melanoma	1.37e-05	0.000103	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CYP17A1—melanoma	1.37e-05	0.000102	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—SLC5A5—melanoma	1.36e-05	0.000102	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.36e-05	0.000102	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.35e-05	0.000101	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—ABCB1—melanoma	1.35e-05	0.000101	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	1.33e-05	9.97e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—GNAQ—melanoma	1.32e-05	9.86e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—CD44—melanoma	1.32e-05	9.86e-05	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—PIK3CA—melanoma	1.31e-05	9.83e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.31e-05	9.82e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—GNA11—melanoma	1.3e-05	9.75e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—GNA11—melanoma	1.29e-05	9.67e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.29e-05	9.65e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.28e-05	9.57e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—FASN—melanoma	1.27e-05	9.55e-05	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—TP53—melanoma	1.27e-05	9.51e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—ABCB1—melanoma	1.27e-05	9.51e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PRKCA—melanoma	1.26e-05	9.48e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.26e-05	9.47e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—FASN—melanoma	1.26e-05	9.46e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—CYP1B1—melanoma	1.26e-05	9.45e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—ERCC2—melanoma	1.25e-05	9.4e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—SLC5A5—melanoma	1.25e-05	9.39e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.25e-05	9.35e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—SLC5A5—melanoma	1.24e-05	9.31e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PRKCA—melanoma	1.24e-05	9.28e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—ERCC2—melanoma	1.23e-05	9.21e-05	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—HRAS—melanoma	1.21e-05	9.1e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—GNAQ—melanoma	1.21e-05	9.07e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CD44—melanoma	1.21e-05	9.07e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—GNAQ—melanoma	1.2e-05	8.99e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CD44—melanoma	1.2e-05	8.99e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PLA2G6—melanoma	1.19e-05	8.91e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.17e-05	8.8e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PRKCA—melanoma	1.17e-05	8.75e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CYP17A1—melanoma	1.17e-05	8.75e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.16e-05	8.72e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—ABCB1—melanoma	1.16e-05	8.72e-05	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—IL6—melanoma	1.16e-05	8.71e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CYP1B1—melanoma	1.16e-05	8.69e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—ERCC2—melanoma	1.16e-05	8.68e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.15e-05	8.63e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CYP1B1—melanoma	1.15e-05	8.62e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	1.14e-05	8.52e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.11e-05	8.34e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—GNA11—melanoma	1.1e-05	8.26e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—FASN—melanoma	1.08e-05	8.09e-05	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—AKT1—melanoma	1.07e-05	8.03e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PRKCA—melanoma	1.07e-05	8.03e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—VCAN—melanoma	1.07e-05	8e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—ERCC2—melanoma	1.06e-05	7.96e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—SLC5A5—melanoma	1.06e-05	7.95e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—ABCB1—melanoma	1.04e-05	7.78e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—GNAQ—melanoma	1.02e-05	7.68e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CD44—melanoma	1.02e-05	7.68e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.01e-05	7.61e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1e-05	7.52e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	9.94e-06	7.45e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PIK3CG—melanoma	9.9e-06	7.42e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CYP1B1—melanoma	9.82e-06	7.36e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PIK3CG—melanoma	9.7e-06	7.27e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	9.59e-06	7.19e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PPARG—melanoma	9.56e-06	7.17e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PRKCA—melanoma	9.56e-06	7.16e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—ABCB1—melanoma	9.55e-06	7.16e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—ERCC2—melanoma	9.48e-06	7.1e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—ABCB1—melanoma	9.47e-06	7.1e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PPARG—melanoma	9.36e-06	7.02e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PIK3CG—melanoma	9.15e-06	6.86e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CYP17A1—melanoma	9.01e-06	6.75e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PPARG—melanoma	8.83e-06	6.62e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	8.8e-06	6.59e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PRKCA—melanoma	8.79e-06	6.59e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—ERCC2—melanoma	8.72e-06	6.53e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PRKCA—melanoma	8.71e-06	6.53e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PIK3CD—melanoma	8.71e-06	6.53e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	8.67e-06	6.5e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—ERCC2—melanoma	8.64e-06	6.48e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—ALB—melanoma	8.6e-06	6.44e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PIK3CD—melanoma	8.53e-06	6.39e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GNA11—melanoma	8.51e-06	6.38e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—ALB—melanoma	8.42e-06	6.31e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PIK3CG—melanoma	8.39e-06	6.29e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—FASN—melanoma	8.32e-06	6.24e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—SLC5A5—melanoma	8.19e-06	6.14e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PPARG—melanoma	8.09e-06	6.07e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—ABCB1—melanoma	8.09e-06	6.06e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PIK3CD—melanoma	8.04e-06	6.03e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—ALB—melanoma	7.94e-06	5.95e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GNAQ—melanoma	7.91e-06	5.93e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CD44—melanoma	7.91e-06	5.93e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	7.85e-06	5.88e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PIK3CB—melanoma	7.59e-06	5.69e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CYP1B1—melanoma	7.58e-06	5.68e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PTGS2—melanoma	7.52e-06	5.64e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PIK3CG—melanoma	7.48e-06	5.61e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PRKCA—melanoma	7.45e-06	5.58e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PIK3CB—melanoma	7.43e-06	5.57e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—ERCC2—melanoma	7.38e-06	5.54e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PIK3CD—melanoma	7.37e-06	5.53e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PTGS2—melanoma	7.37e-06	5.52e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—ALB—melanoma	7.28e-06	5.46e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PPARG—melanoma	7.22e-06	5.42e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	7.16e-06	5.37e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PIK3CB—melanoma	7.01e-06	5.25e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PTGS2—melanoma	6.94e-06	5.21e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PIK3CG—melanoma	6.88e-06	5.16e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PIK3CG—melanoma	6.82e-06	5.12e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PPARG—melanoma	6.64e-06	4.98e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PPARG—melanoma	6.59e-06	4.94e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PIK3CD—melanoma	6.58e-06	4.93e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PTEN—melanoma	6.56e-06	4.92e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—ALB—melanoma	6.5e-06	4.87e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PIK3CB—melanoma	6.43e-06	4.82e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PTEN—melanoma	6.42e-06	4.82e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PTGS2—melanoma	6.37e-06	4.77e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—ABCB1—melanoma	6.24e-06	4.68e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.12e-06	4.59e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PTEN—melanoma	6.06e-06	4.54e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PIK3CD—melanoma	6.05e-06	4.54e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PIK3CD—melanoma	6e-06	4.5e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—ALB—melanoma	5.97e-06	4.48e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—ALB—melanoma	5.92e-06	4.44e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PIK3CG—melanoma	5.83e-06	4.37e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PRKCA—melanoma	5.75e-06	4.31e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PIK3CB—melanoma	5.74e-06	4.3e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—ERCC2—melanoma	5.7e-06	4.27e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PTGS2—melanoma	5.68e-06	4.26e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PPARG—melanoma	5.63e-06	4.22e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PTEN—melanoma	5.55e-06	4.16e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PIK3CB—melanoma	5.27e-06	3.95e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PIK3CB—melanoma	5.23e-06	3.92e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PTGS2—melanoma	5.23e-06	3.92e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PTGS2—melanoma	5.18e-06	3.88e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PIK3CD—melanoma	5.13e-06	3.84e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—ALB—melanoma	5.06e-06	3.79e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PTEN—melanoma	4.96e-06	3.72e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PIK3CA—melanoma	4.63e-06	3.47e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PTEN—melanoma	4.56e-06	3.42e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PIK3CA—melanoma	4.53e-06	3.4e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PTEN—melanoma	4.52e-06	3.39e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PIK3CG—melanoma	4.5e-06	3.37e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PIK3CB—melanoma	4.47e-06	3.35e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PTGS2—melanoma	4.43e-06	3.32e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PPARG—melanoma	4.34e-06	3.26e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PIK3CA—melanoma	4.27e-06	3.2e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PIK3CD—melanoma	3.96e-06	2.97e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PIK3CA—melanoma	3.92e-06	2.94e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—ALB—melanoma	3.91e-06	2.93e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PTEN—melanoma	3.86e-06	2.89e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—AKT1—melanoma	3.78e-06	2.83e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—AKT1—melanoma	3.7e-06	2.78e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PIK3CA—melanoma	3.5e-06	2.62e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—AKT1—melanoma	3.49e-06	2.62e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PIK3CB—melanoma	3.45e-06	2.59e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PTGS2—melanoma	3.42e-06	2.56e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PIK3CA—melanoma	3.22e-06	2.41e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—AKT1—melanoma	3.2e-06	2.4e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PIK3CA—melanoma	3.19e-06	2.39e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PTEN—melanoma	2.98e-06	2.23e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—AKT1—melanoma	2.86e-06	2.14e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PIK3CA—melanoma	2.72e-06	2.04e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—AKT1—melanoma	2.63e-06	1.97e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—AKT1—melanoma	2.6e-06	1.95e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—AKT1—melanoma	2.23e-06	1.67e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PIK3CA—melanoma	2.1e-06	1.58e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—AKT1—melanoma	1.72e-06	1.29e-05	CbGpPWpGaD
